1)荒川宜親,加藤延夫:細菌の病原性.医系微生物学(加藤延夫編),朝倉出版,pp50-58,1996
2)Arakawa Y, Wacharotayankun R, Nagatsuka T, et al:Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol 177:1788-1796,1995
3)Minami J, Saito S, Yoshida T, et al:Biological activities and chemical composition of a cytotoxin of Klebsiella oxytoca. J Gen Microbiol 138:1921-1927,1992
4)Bush K, Fisher JF:Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol 65:455-478,2011
5)荒川宜親:多剤耐性菌の現状について.臨床検査 56:817-826,2012
6)Suzuki S, Shibata N, Yamane K, et al:Change in the prevalence of extended-spectrum-beta-lactamase-producing
Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63:72-79,2009
7)荒川宜親:カルバペネム耐性腸内細菌科細菌.平成25年度厚生労働科学研究費補助金新型インフルエン等新興・再興感染症研究事業「医療機関における感染制御に関する研究」班(研究代表者 八木哲也),2014(http://yakutai.dept.med.gunma-u.ac.jp/society/pdf/CRE%20Fact%20Sheet%2020140320.pdf)
8)Hattori T, Kawamura K, Arakawa Y:Comparison of test methods for detecting metallo-β-lactamase-producing Gram-negative bacteria. Jpn J Infect Dis 66:512-518,2013
9)Nagano N, Endoh Y, Nagano Y, et al:First report of OXA-48 carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Japan from a patient returned from Southeast Asia. Jpn J Infect Dis 66:79-81,2013
10)長野則之,長野由紀子,荒川宜親:話題の薬剤耐性菌 新型カルバペネマーゼOXA-48型産生Enterobacteriaceaeの出現.日本臨床微生物学雑誌 23:175-185,2013